Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1995
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026742A1 Immunotherapeutic agent and its use
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995026713A1 Heterofunctional, mucoadhesive dosage form
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186863A1 Heterofunctional, mucoadhesive dosage form
10/12/1995CA2186857A1 Monoclonal antibody to oncofetal protein for treating and detecting cancer
10/12/1995CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995CA2186250A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995CA2184756A1 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/12/1995CA2182700A1 Screening method using the rzr receptor family
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells
10/11/1995EP0676201A2 Use of a riminophenazine for treating MDR resistance
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675956A1 New protein from urine named component b
10/11/1995EP0675902A1 Endothelin antagonists
10/11/1995EP0675895A1 Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer.
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675733A1 Peptide-carbohydrate conjugates generating t-cell immunity
10/11/1995EP0675729A1 ACTIVATION OF p53 PROTEIN
10/11/1995EP0675719A1 Novel combination of benzoquinazoline antifolates and protecting agents
10/11/1995EP0675715A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
10/11/1995EP0538330B1 Beta-alethine use in cell culture and therapy
10/11/1995EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
10/11/1995CN1110055A Taxane having antitumor activity
10/11/1995CN1109908A Productive process and use of human anti-tumour alpha type interferon alpha 1/114 Ala, alpha 1/158 Val and mutant thereof
10/11/1995CN1109886A Method for preparing thioether conjugates
10/10/1995US5457237 Used in treating cancer and-or atherosclerosis
10/10/1995US5457209 4-[α(cyanophenyl)-1-(1,2,3-triazolyl)methyl]-benzonitrile
10/10/1995US5457189 Antisense oligonucleotide inhibition of papillomavirus
10/10/1995US5457183 Radiosensitizers
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457119 A89271 factors and processes for their production
10/10/1995US5457105 Quinazoline derivatives useful for treatment of neoplastic disease
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995CA2042032C Therapeutic agent and method of inhibiting vascularization of tumors
10/06/1995CA2144783A1 Mdr resistance treatment
10/05/1995WO1995026364A1 Monoclonal antibodies recognizing tie-receptor and their use
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026341A1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026189A1 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS[(2-AMINOETHYL)AMINO]BENZO[g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/04/1995EP0675120A2 Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
10/04/1995EP0675112A1 Imidazole-containing inhibitors of farnesyl protein transferase
10/04/1995EP0674716A1 Retroviral vectors for the treatment of tumors, and cell lines containing them
10/04/1995EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity
10/04/1995EP0674658A1 A novel protein tyrosine kinase
10/04/1995EP0674652A1 Dolostatin analog
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/04/1995EP0674630A1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/04/1995EP0674626A1 Novel selective aromatase inhibiting compounds
10/04/1995EP0674529A1 Lipid prodrugs for oral administration
10/04/1995CN1109507A Preparation for high efficiency anti-tumor gama-type interferon mutant and use
10/04/1995CN1109330A Methods of inhibiting imperfect tissue repair
10/03/1995US5455348 Anticoagulants
10/03/1995US5455275 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
10/03/1995US5455270 Stabilized solutions of platinum(II) antitumor agents
10/03/1995US5455258 Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase
10/03/1995US5455241 Staurosporin derivatives as enzyme inhibitors for protein kinase C and platelet-derived growth factor kinase; antitumor agents, bactericides, antigrowth agents
10/03/1995US5455233 Detectors, antiinflammatory, antilipemic agents and antitumor agents
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995CA1337200C .beta.-carbolines, their bio-isosteric benzofuran and benzothiophene analogues having cytostatic properties
10/03/1995CA1337177C Bioparyl, a biological regulator, active against various pathologies
10/03/1995CA1337176C Pharmaceutical compositions for the inhibition of tumor metastasis
10/01/1995CA2146059A1 Imidazole-containing inhibitors of farnesyl protein transferase
09/1995
09/28/1995WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025741A1 Gnrh antagonists
09/28/1995WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/28/1995WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis
09/28/1995WO1995025542A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995WO1995025526A1 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same
09/28/1995WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/28/1995WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/28/1995CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/28/1995CA2185710A1 Gnrh antagonists
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/27/1995EP0673937A1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
09/27/1995EP0673380A1 Water soluble camptothecin derivatives
09/27/1995EP0673379A1 Antitumour agents
09/27/1995EP0673376A1 Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds.
09/27/1995EP0673372A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
1 ... 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 ... 2211